Abstract Background It is well known that decision aids can promote patients’ participation in decision-making, increase patients’ decision preparation and reduce decision conflict. The goal of this study is to explore the effects of a “Shared Decision Making Assistant” smartphone application on the decision-making of informed patients with Primary Liver Cancer (PLC) in China. Methods In this quasi-experimental study , 180 PLC patients who knew their real diagnoses in the Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China, from April to December 2020 were randomly assigned to a control group and an intervention group. Patients in the intervention group had an access to the “Shared Decision Making Assistant” application in decision-making, which included primary liver cancer treatment knowledge, decision aids path, continuing nursing care video clips, latest information browsing and interactive platforms. The study used decision conflict scores to evaluate the primary outcome, and the data of decision preparation, decision self-efficacy, decision satisfaction and regret, and knowledge of PLC treatment for secondary outcomes. Then, the data were entered into the SPSS 22.0 software and were analyzed by descriptive statistics, Chi-square, independent t-test, paired t-test, and Mann–Whitney tests. Results Informed PLC patients in the intervention group (“SDM Assistant” group) had significantly lower decision conflict scores than those in the control group. (“SDM Assistant” group: 16.89 ± 8.80 vs. control group: 26.75 ± 9.79, P < 0.05). Meanwhile, the decision preparation score (80.73 ± 8.16), decision self-efficacy score (87.75 ± 6.87), decision satisfaction score (25.68 ± 2.10) and knowledge of PLC treatment score (14.52 ± 1.91) of the intervention group were significantly higher than those of the control group patients (P < 0.05) at the end of the study. However, the scores of “regret of decision making” between the two groups had no statistical significance after 3 months (P > 0.05). Conclusions Access to the “Shared Decision Making Assistant” enhanced the PLC patients’ performance and improved their quality of decision making in the areas of decision conflict, decision preparation, decision self-efficacy, knowledge of PLC treatment and satisfaction. Therefore, we recommend promoting and updating the “Shared Decision Making Assistant” in clinical employment and future studies.

The development of medical technology provides medical specialists with a variety of choices for their primary liver cancer patients, including partial liver resection, transcatheter arterial chemoembolization, liver transplantation, and so on. However, in this context, because patients with primary liver cancer frequently do not receive adequate information to help make complicated medical decisions, those patients, who are usually otherwise ignorant about their disease, are facing multiple difficult choices. The problem might be alleviated with a process called "shared decision making." Accordingly, researchers developed a smartphone application named "Shared Decision Making Assistant" for primary liver cancer patients in China, and in this article, we report the process of its development. First, individual interviews were conducted to identify the specific needs and status of primary liver cancer patients participating in shared decision making. Next, expert group discussions were held among primary liver cancer medical experts, nurses, and software engineers, using a decision-making process called the Delphi method, which was used to arrive at a group opinion or decision by surveying a panel of experts, to draft the framework and decide on the contents of the mobile health-based decision aids program. Feedbacks and suggestions were collected to optimize the workflow of "Shared Decision Making Assistant." The resulting application consisted of seven modules: personal information, primary liver cancer treatment knowledge center, decision aids path, continuing care, interactive platform, health education, and backstage management.

目的 原创性研发基于移动技术的原发性肝癌患者治疗决策辅助平台,辅助患者了解肝癌疾病治疗信息,提高医患沟通效率,提升共享决策质量.方法 基于加拿大渥太华决策支持框架,利用微信小程序构建"平台",包含肝癌不同治疗方案知识库、肝癌患者决策辅助路径、延续护理以及医患沟通功能四个核心模块.结果 实现决策辅助工具实时指导、决策路径实时评估、健康科普、咨询等功能.结论 建立以原发性肝癌患者为中心的治疗决策辅助平台,在不增加医务人员工作负担的同时,方便患者随时获取决策知识,并通过医护患之间的良好互动提升决策质量;也为我国决策辅助的发展提供新路径.